These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 17202157

  • 1. DNA methylation immediately adjacent to active histone marking does not silence transcription.
    Brinkman AB, Pennings SW, Braliou GG, Rietveld LE, Stunnenberg HG.
    Nucleic Acids Res; 2007; 35(3):801-11. PubMed ID: 17202157
    [Abstract] [Full Text] [Related]

  • 2. Coordinated changes in DNA methylation and histone modifications regulate silencing/derepression of luteinizing hormone receptor gene transcription.
    Zhang Y, Fatima N, Dufau ML.
    Mol Cell Biol; 2005 Sep; 25(18):7929-39. PubMed ID: 16135786
    [Abstract] [Full Text] [Related]

  • 3. Aberrant de novo methylation of the p16INK4A CpG island is initiated post gene silencing in association with chromatin remodelling and mimics nucleosome positioning.
    Hinshelwood RA, Melki JR, Huschtscha LI, Paul C, Song JZ, Stirzaker C, Reddel RR, Clark SJ.
    Hum Mol Genet; 2009 Aug 15; 18(16):3098-109. PubMed ID: 19477956
    [Abstract] [Full Text] [Related]

  • 4. Epigenetic regulation of CIITA expression in human T-cells.
    van Eggermond MC, Boom DR, Klous P, Schooten E, Marquez VE, Wierda RJ, Holling TM, van den Elsen PJ.
    Biochem Pharmacol; 2011 Nov 15; 82(10):1430-7. PubMed ID: 21664896
    [Abstract] [Full Text] [Related]

  • 5. Positive histone marks are associated with active transcription from a methylated ICSBP/IRF8 gene.
    Tshuikina M, Nilsson K, Oberg F.
    Gene; 2008 Mar 15; 410(2):259-67. PubMed ID: 18242011
    [Abstract] [Full Text] [Related]

  • 6. Tissue-specific and imprinted epigenetic modifications of the human NDN gene.
    Lau JC, Hanel ML, Wevrick R.
    Nucleic Acids Res; 2004 Mar 15; 32(11):3376-82. PubMed ID: 15247330
    [Abstract] [Full Text] [Related]

  • 7. Epigenetic mechanism of rRNA gene silencing: temporal order of NoRC-mediated histone modification, chromatin remodeling, and DNA methylation.
    Santoro R, Grummt I.
    Mol Cell Biol; 2005 Apr 15; 25(7):2539-46. PubMed ID: 15767661
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Regulation of transcription of the steroidogenic acute regulatory protein (StAR) gene: temporal and spatial changes in transcription factor binding and histone modification.
    Hiroi H, Christenson LK, Strauss JF.
    Mol Cell Endocrinol; 2004 Feb 27; 215(1-2):119-26. PubMed ID: 15026184
    [Abstract] [Full Text] [Related]

  • 10. Epigenetic control of ovarian function: the emerging role of histone modifications.
    LaVoie HA.
    Mol Cell Endocrinol; 2005 Nov 24; 243(1-2):12-8. PubMed ID: 16219412
    [Abstract] [Full Text] [Related]

  • 11. Novel relationships among DNA methylation, histone modifications and gene expression in Ascobolus.
    Barra JL, Holmes AM, Grégoire A, Rossignol JL, Faugeron G.
    Mol Microbiol; 2005 Jul 24; 57(1):180-95. PubMed ID: 15948959
    [Abstract] [Full Text] [Related]

  • 12. Epigenetic interplay between histone modifications and DNA methylation in gene silencing.
    Vaissière T, Sawan C, Herceg Z.
    Mutat Res; 2008 Jul 24; 659(1-2):40-8. PubMed ID: 18407786
    [Abstract] [Full Text] [Related]

  • 13. Promoter-restricted histone code, not the differentially methylated DNA regions or antisense transcripts, marks the imprinting status of IGF2R in human and mouse.
    Vu TH, Li T, Hoffman AR.
    Hum Mol Genet; 2004 Oct 01; 13(19):2233-45. PubMed ID: 15294879
    [Abstract] [Full Text] [Related]

  • 14. Developmental changes in DNA methylation and covalent histone modifications of chromatin associated with the epsilon-, gamma-, and beta-globin gene promoters in Papio anubis.
    Lavelle D, Vaitkus K, Hankewych M, Singh M, DeSimone J.
    Blood Cells Mol Dis; 2006 Oct 01; 36(2):269-78. PubMed ID: 16527500
    [Abstract] [Full Text] [Related]

  • 15. Nucleosomes at active promoters: unforgettable loss.
    Henikoff S.
    Cancer Cell; 2007 Nov 01; 12(5):407-9. PubMed ID: 17996642
    [Abstract] [Full Text] [Related]

  • 16. Epigenetic changes in solid and hematopoietic tumors.
    Toyota M, Issa JP.
    Semin Oncol; 2005 Oct 01; 32(5):521-30. PubMed ID: 16210093
    [Abstract] [Full Text] [Related]

  • 17. Retinoic acid receptor beta2 is epigenetically silenced either by DNA methylation or repressive histone modifications at the promoter in cervical cancer cells.
    Zhang Z, Joh K, Yatsuki H, Zhao W, Soejima H, Higashimoto K, Noguchi M, Yokoyama M, Iwasaka T, Mukai T.
    Cancer Lett; 2007 Mar 18; 247(2):318-27. PubMed ID: 16806674
    [Abstract] [Full Text] [Related]

  • 18. Stability of histone modifications across mammalian genomes: implications for 'epigenetic' marking.
    Lee BM, Mahadevan LC.
    J Cell Biochem; 2009 Sep 01; 108(1):22-34. PubMed ID: 19623574
    [Abstract] [Full Text] [Related]

  • 19. Uteroplacental insufficiency affects epigenetic determinants of chromatin structure in brains of neonatal and juvenile IUGR rats.
    Ke X, Lei Q, James SJ, Kelleher SL, Melnyk S, Jernigan S, Yu X, Wang L, Callaway CW, Gill G, Chan GM, Albertine KH, McKnight RA, Lane RH.
    Physiol Genomics; 2006 Mar 13; 25(1):16-28. PubMed ID: 16380407
    [Abstract] [Full Text] [Related]

  • 20. Plakoglobin is differentially expressed in alveolar and embryonal rhabdomyosarcoma and is regulated by DNA methylation and histone acetylation.
    Gastaldi T, Bonvini P, Sartori F, Marrone A, Iolascon A, Rosolen A.
    Carcinogenesis; 2006 Sep 13; 27(9):1758-67. PubMed ID: 16537559
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.